BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Biotech Bay

  SI-BONE Announces Publication Of 6-Year Clinical Results Demonstrating Long-Term Positive Outcomes Of iFuse Implant System

  April 24, 2017

   · 

  5 min read
• Drug Development

  DURECT Announces Presentation Of Data From A Phase Ib Study Of DUR-928 In Nonalcoholic Steatohepatitis (NASH) At The International Liver Congress 2017

  April 24, 2017

   · 

  6 min read
• Biotech Bay

  BioMarin Receives Positive CHMP Opinion In Europe For Brineura (Cerliponase Alfa) For First Treatment Of CLN2 Disease, A Form Of Batten Disease And Ultra-Rare And Fatal Brain Disorder In Children

  April 24, 2017

   · 

  8 min read
• Drug Development

  Pfizer Receives Positive CHMP Opinion For BESPONSA (Inotuzumab Ozogamicin) For The Treatment Of Relapsed Or Refractory Acute Lymphoblastic Leukemia

  April 24, 2017

   · 

  9 min read
• Drug Development

  Shionogi Presents New Clinical And Non-Clinical Data On S-033188, An Investigational Cap-Dependent Endonuclease Inhibitor For Treatment Of Influenza, At The 27th European Congress Of Clinical Microbiology And Infectious Diseases

  April 24, 2017

   · 

  4 min read
• BioGX Launches Four CE-Marked IVD Assays At The European Congress Of Clinical Microbiology And Infectious Diseases (ECCMID)

  April 24, 2017

   · 

  2 min read
• Business

  Diaceutics Signs Multi-Million-Dollar Partnership With BioReference To Improve Patient Outcomes

  April 24, 2017

   · 

  4 min read
• BioCapital

  CEL-SCI Releases Letter To Shareholders

  April 24, 2017

   · 

  5 min read
• Business

  Teleflex Inc. Announces First Quarter 2017 Earnings Conference Call Information

  April 24, 2017

   · 

  1 min read
• Drug Development

  Pfizer Release: Pivotal Phase III Study Underscores Efficacy Of Zavicefta (ceftazidime-avibactam) For Treatment Of Hospital-Acquired Pneumonia, A Leading Cause Of Mortality In Hospitals

  April 24, 2017

   · 

  9 min read